Agios Pharmaceuticals Incの内部者の所有権
Agios Pharmaceuticals Incの内部者の所有権は何ですか。
Agios Pharmaceuticals Incの内部者の所有権は1.35%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
NASDAQのセクタHealth Careにおける内部者の所有権の企業と比べるAgios Pharmaceuticals Inc
Agios Pharmaceuticals Incは何をしますか。
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Agios Pharmaceuticals Incと類似の内部者の所有権
- Blucora Incの内部者の所有権は1.34%です。
- Genworth Incの内部者の所有権は1.34%です。
- Intercontinental Exchangeの内部者の所有権は1.34%です。
- Genprex Incの内部者の所有権は1.34%です。
- Intercontinental Exch.Incの内部者の所有権は1.34%です。
- Collegium Pharmaceutical Incの内部者の所有権は1.34%です。
- Agios Pharmaceuticals Incの内部者の所有権は1.35%です。
- Dnow Incの内部者の所有権は1.35%です。
- Bonanza Creek Incの内部者の所有権は1.35%です。
- Wajaxの内部者の所有権は1.35%です。
- RiverNorth Opportunities Fund Incの内部者の所有権は1.35%です。
- Sonos Incの内部者の所有権は1.35%です。
- NetEase Incの内部者の所有権は1.35%です。